CDK12 and prostate carcinoma: One such gene, CDK12, has been associated with response to immunotherapy in prostate cancer.31,32 Prostate cancers in Black men and men of African ancestry have been reported to have higher rates of DNA repair deficiency33,34 and increased TMB35 compared with men of European ancestry.